Latest heart attack Stories
In Honor of Mother's Day, Campaign Looks to Raise $200,000 for WomenHeart and Awareness Among 42 Million Women With or at Risk of Heart Disease MORRISTOWN, N.J., May 7, 2013 /PRNewswire/ -- Bayer HealthCare, the makers of Bayer® Aspirin, WomenHeart: The National Coalition for Women with Heart Disease, and actress, singer and author Vanessa Williams today announce their partnership to launch Handbags & Hearts, a national campaign that leverages the link between women and their...
-- Phase II, randomized, placebo-controlled study at Glenfield Hospital, University of Leicester (UK) will measure primary efficacy endpoint of change from baseline in left ventricular ejection fraction (LVEF) post-percutaneous coronary intervention (PCI) -- TORONTO, May 2, 2013 /PRNewswire/ -- CellAegis Devices, Inc., announced today the first clinical trial program in the European Union to evaluate the use of the Company's autoRIC(TM) Device for Chronic Remote Ischemic Conditioning...
Recent study finds that door-to-balloon times can be lowered using process improvement strategies While all heart attacks have the potential to be deadly, one type is referred to as the “widow maker” because of its high risk of death. A ST segment elevation myocardial infarction (STEMI) is a severe type of heart attack that occurs when a blockage in a coronary artery causes heart muscle to die; without prompt treatment risk of fatality increases dramatically. Coronary angioplasty, or...
Recent study finds that door-to-balloon times can be lowered using process improvement strategies CHICAGO, April 29, 2013 /PRNewswire-USNewswire/ -- While all heart attacks have the potential to be deadly, one type is referred to as the "widow maker" because of its high risk of death. A ST segment elevation myocardial infarction (STEMI) is a severe type of heart attack that occurs when a blockage in a coronary artery causes heart muscle to die; without prompt treatment risk of...
Clinical study in over 4,000 subjects finds blood TMAO levels linked to increased risk of heart disease, even in the absence of known cardiovascular risks A microbial byproduct of intestinal bacteria contributes to heart disease and serves as an accurate screening tool for predicting future risks of heart attack, stroke and death in persons not otherwise identified by traditional risk factors and blood tests, according to Cleveland Clinic research published today in The New England Journal...
DENVER, April 24, 2013 /PRNewswire-USNewswire/ -- Omega-3 polyunsaturated fatty acids (PUFAs), namely DHA and EPA found in fatty fish, are associated with lower risk of heart failure mortality in adults with chronic heart failure or who have experienced a heart attack. These fatty acids may also benefit young adults at risk of cardiovascular disease due to impaired fetal growth and low birth weight. These findings and more are summarized in the April 2013 PUFA Newsletter. A study of...
Silicon BioDevices 'Lab-in-the-Hand' Previewed at 45th Annual Oak Ridge Conference BALTIMORE, April 18, 2012 /PRNewswire/ -- Silicon BioDevices, based in Berkeley, Calif., today presented the results of a pivotal benchmark study of its digital handheld device for high-sensitivity measurement of cardiac troponin-I, a protein found in the heart muscle used to identify heart tissue damage in patients suspected of having a heart attack. The study showed that the totally integrated,...
If you suffer a heart attack while walking down the street and are taken to the hospital quickly, your chances of survival are very good. But if you have a heart attack while already in the hospital for something else, you are 10 times more likely to die. That surprising finding comes from a study by University of North Carolina School of Medicine researchers. Their study, which is the first to systematically examine outcomes among hospital inpatients who suffer a type of heart attack...
Seeing a doctor within a month of an emergency room visit for chest pain significantly reduced the risk of heart attack or death among high risk patients, according to research published the American Heart Association journal Circulation. Chest pain is the most common reason people go to the emergency room in developed countries and accounts for more than 5 million ER visits each year in the United States. The study is the first to demonstrate the importance of follow-up care for chest...
Study on treatment for heart attack patients led by the Montreal Heart Institute A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial spearheaded by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, affiliated with the University of Montreal. Presented today in San Francisco at the...
